Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profiling of liver samples from WT and AKAP12 KO mice after inducing fibrosis resolution

ABSTRACT: Transcriptome profiling of liver samples from WT and AKAP12 KO mice after inducing fibrosis resolution

PROVIDER: PRJNA408066 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome profiling of liver samples from WT and AKAP12 KO mice after inducing fibrosis resolution

Project description:AKAP12 KO mice showed reduced fibrosis resolution in DDC-induced hepatic fibrosis and resolution model. To compare gene expression profile between genotypes, transcriptome was analyzed by RNA sequencing.

2018-09-01 | GSE104030 | GEO

Transcriptional programme in Glmp KO mouse liver fibrosis model

Project description:Transcriptome of 8 and 18 weeks old mice where fibrosis developed upon the full-body knocking-out gene Glmp (glycosylated lysosomal membrane protein) (Glmpgt/gt; Glmp KO) Glmp KO mice were compared to their wild-type (WT) littermates

2021-02-01 | GSE154021 | GEO

Liver samples from WT and Atg7 liver specific KO mice

Project description:iTRAQ proteomics was performed for Liver samples from WT and Atg7 liver specific KO mice

2023-07-20 | PXD043936 | iProX

Bleomycin model of fibrosis and resolution phase in old and young mice

Project description:Bleomycin-induced pulmonary fibrosis in mice mimics major hallmarks of idiopathic pulmonary fibrosis, yet in this model it spontaneously resolves over time. We studied molecular mechanisms of fibrosis resolution and lung repair, focusing on transcriptional and proteomic signatures and the effect of aging. Young (3 months) and old (21 months) mice were treated with Bleomycin or with control saline solution and analyzed transcript and protein expression over 8 weeks (Day 0, 14, 21, 28, 35, 42, 49, 56).

2023-08-09 | PXD041050 | Pride

Spontaneous lung fibrosis resolution reveals novel anti-fibrotic regulators

Project description:Spontaneous lung fibrosis resolution reveals novel anti-fibrotic regulators

| PRJNA677893 | ENA

Kdm3a in mouse promotes pressure overload induced cardiac hypertrophy [WT vs. KO]

Project description:Heart disease and failure is a leading cause of mortality worldwide. Left ventricular hypertrophy (LVH) is a major risk factor for cardiovascular morbidity and mortality and the development of heart failure. Pathological LVH induced by sustained pressure-overload engages transcriptional programs including reactivation of canonical fetal genes and those inducing fibrosis. Histone lysine demethylases (KDMs) are emerging potent regulators of transcriptional reprogramming in cancer, though their potential role in abnormal growth and fibrosis in heart disease remains little understood. Here, we investigated gain and loss of function of an H3K9me2 specific demethylase, Kdm3a, in myocytes and in vivo, and show it promotes LVH and myocardial fibrosis in response to pressure-overload. Cardiomyocyte KDM3A activates the transcription of tissue-inhibitor of MMP type 1 (Timp1) with pro-fibrotic activity. By contrast, a pan-KDM inhibitor, JIB-04, suppresses TAC-induced LVH and fibrosis. JIB-04 inhibits KDM3A and suppresses the transcription of fibrotic genes that overlap with genes downregulated in Kdm3a-KO mice versus WT controls. Our study provides genetic and biochemical evidence for a pro-hypertrophic function of KDM3A and proof-of principle for pharmacological targeting of KDMs as an effective strategy to counter LVH and pathological fibrosis.

2018-10-09 | GSE120739 | GEO

Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis

Project description:Liver fibrosis results from chronic liver injury triggered by factors such as viral infection, excess alcohol intake, and lipid accumulation. However, the mechanisms underlying liver fibrosis are not fully understood. Here, we demonstrate that expression of Fibroblast growth factor 18 (Fgf18) is elevated in the livers of mice following induction of chronic liver fibrosis models. Deletion and overexpression of Fgf18 in hepatocytes attenuate and promote liver fibrosis, respectively. Single-cell RNA-sequencing revealed that Lrat+ quiescent hepatic stellate cells (HSCs) are increased in the livers of Fgf18 transgenic mice. Mechanistically, FGF18 stimulates the proliferation of quiescent HSCs by inducing the expression of Ccnd1, resulting in the development of liver fibrosis. Moreover, the expression of FGF18 is correlated with the expression of profibrotic genes, such as COL1A1 and ACTA2, in human liver biopsy samples. Thus, FGF18 promotes liver fibrosis and could serve as a therapeutic target to treat liver fibrosis.

2023-09-26 | GSE188273 | GEO

Transcriptional programme in Glmp KO mouse liver fibrosis model

Project description:Transcriptional programme in Glmp KO mouse liver fibrosis model

| PRJNA644881 | ENA

Individual-nucleotide resolution CLIP and high-throughput sequencing for FOX2, TDP43 and hnRNP M in WT and P-KO H9 cells

Project description:Individual-nucleotide resolution UV-crosslinking and immunoprecipitation (iCLIP) combined with high-throughput sequencing was used to generate a transcriptome-wide binding map of TDP43, FOX2 and hnRNP M in WT and P-KO H9 cells.

2016-10-13 | GSE85851 | GEO

Redox-sensitive High-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in mice

Project description:To study role of different HMGB1 isoforms in liver fibrosis and resolution

2023-09-30 | GSE233751 | GEO